Hélène Vergneault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hélène Vergneault has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Sophie Georgin-Lavialle
Assistance‐Publique Hôpitaux de Paris, Hôpital Tenon, Service de Médecine Interne, Bâtiment Gabriel Paris France
3 shared publications Anael Dumont
Department of Internal Medicine, Tenon Hospital, AP-HP, Sorbonne University, Paris, France
2 shared publicationsGilles Grateau
Department of Internal Medicine, Tenon Hospital, AP-HP, Sorbonne University, Paris, France
2 shared publicationsLéa Savey
Department of Internal Medicine, Tenon Hospital, AP-HP, Sorbonne University, Paris, France
2 shared publicationsSamuel Ardois
Department of Internal Medicine, Tenon Hospital, AP-HP, Sorbonne University, Paris, France
2 shared publicationsAchille Aouba
Department of Internal Medicine; Caen; Normandie Univ; UNICAEN; CHU de Caen Normandie; France
1 shared publication
Latest Publications
- Open Access
- 3 October 2022
- Published by Wiley in Immunology
- Vol. 168 (1) , 1-17
Break down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022?
In the past few years, the spectrum of monogenic systemic auto‐inflammatory diseases (MSAID) has widely expanded beyond the typical recurrent fever. Immuno‐haematological features, as cytopenias, hypogammaglobulinemia, hypereosinophilia, lymphoproliferation and immunodeficiency, have been described in association of several MSAID. The objective of this review was to describe these particular MSAID. MSAID must be suspected in front of immuno‐haematological features associated with non‐infectious recurrent fever, chronic systemic inflammation, inflammatory cutaneous manifestations, arthritis or inflammatory bowel disease. Genes and cellular mechanisms involved are various but some of them are of special interest. Defects in actine regulation pathway are notably associated with cytopenia and immune deficiency. Because of their frequency, ADA2 deficiency and Vacuoles, E1‐Enzyme, X‐linked, auto‐inflammatory, Somatic (VEXAS) syndrome deserve to be noticed. ADA2 deficiency results in polyarteritis nodosa‐like presentation with a wide panel of manifestations including cytopenia(s), lymphoproliferation and immune deficiency. Neutrophilic dermatosis or chondritis associated with macrocytic anaemia or myelodysplasia should lead to screen for VEXAS. Of note, most of MSAID are associated with inflammatory anaemia. We proposed here a clinical and pragmatic approach of MSAID associated with immuno‐haematological features.
- 3 October 2022
- Published by Wiley in Immunology
- Vol. 168 (1) , 1-17
Open AccessBreak down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022?
In the past few years, the spectrum of monogenic systemic auto‐inflammatory diseases (MSAID) has widely expanded beyond the typical recurrent fever. Immuno‐haematological features, as cytopenias, hypogammaglobulinemia, hypereosinophilia, lymphoproliferation and immunodeficiency, have been described in association of several MSAID. The objective of this review was to describe these particular MSAID. MSAID must be suspected in front of immuno‐haematological features associated with non‐infectious recurrent fever, chronic systemic inflammation, inflammatory cutaneous manifestations, arthritis or inflammatory bowel disease. Genes and cellular mechanisms involved are various but some of them are of special interest. Defects in actine regulation pathway are notably associated with cytopenia and immune deficiency. Because of their frequency, ADA2 deficiency and Vacuoles, E1‐Enzyme, X‐linked, auto‐inflammatory, Somatic (VEXAS) syndrome deserve to be noticed. ADA2 deficiency results in polyarteritis nodosa‐like presentation with a wide panel of manifestations including cytopenia(s), lymphoproliferation and immune deficiency. Neutrophilic dermatosis or chondritis associated with macrocytic anaemia or myelodysplasia should lead to screen for VEXAS. Of note, most of MSAID are associated with inflammatory anaemia. We proposed here a clinical and pragmatic approach of MSAID associated with immuno‐haematological features.
- 6 July 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (8) , 3381-3382
Thyroid disorders in familial Mediterranean fever: think about AA amyloidosis!
- 6 July 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (8) , 3381-3382
Thyroid disorders in familial Mediterranean fever: think about AA amyloidosis!
- Open Access
- 5 May 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (9) , 1983
Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review
Our aim was to describe the main features of amyloid goiter in adults with amyloidosis secondary to familial Mediterranean fever. Therefore, we analyzed cases from a French cohort of familial Mediterranean fever patients with amyloidosis and from literature review. Forty-two cases were identified: 9 from the French cohort and 33 from literature review. Ninety percent of patients were on hemodialysis for renal amyloidosis before the development of goiter. The goiter grew up rapidly in 88% of cases; 75.6% of patients were euthyroid, 58% displayed dyspnea, and 44.8% dysphagia. Various features were seen on ultrasound, from diffuse to multinodular goiter. When it was performed, fine-needle aspiration biopsy almost always revealed amyloidosis. Thirty-one patients underwent thyroidectomy: to manage compressive symptoms (72%) or rule out malignancy (27%). Histology showed mature adipose tissue in 64% of cases and lymphocytic infiltration in 21.4%. In conclusion, amyloid goiter in familial Mediterranean fever preferentially occurs in patients with end stage renal failure. Fine-needle aspiration biopsy seems to be a sensitive exam for diagnosis, but thyroidectomy remains sometimes necessary to rule out malignancy or release compressive symptoms.
- 5 May 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (9) , 1983
Open AccessAmyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review
Our aim was to describe the main features of amyloid goiter in adults with amyloidosis secondary to familial Mediterranean fever. Therefore, we analyzed cases from a French cohort of familial Mediterranean fever patients with amyloidosis and from literature review. Forty-two cases were identified: 9 from the French cohort and 33 from literature review. Ninety percent of patients were on hemodialysis for renal amyloidosis before the development of goiter. The goiter grew up rapidly in 88% of cases; 75.6% of patients were euthyroid, 58% displayed dyspnea, and 44.8% dysphagia. Various features were seen on ultrasound, from diffuse to multinodular goiter. When it was performed, fine-needle aspiration biopsy almost always revealed amyloidosis. Thirty-one patients underwent thyroidectomy: to manage compressive symptoms (72%) or rule out malignancy (27%). Histology showed mature adipose tissue in 64% of cases and lymphocytic infiltration in 21.4%. In conclusion, amyloid goiter in familial Mediterranean fever preferentially occurs in patients with end stage renal failure. Fine-needle aspiration biopsy seems to be a sensitive exam for diagnosis, but thyroidectomy remains sometimes necessary to rule out malignancy or release compressive symptoms.